Survival after disseminated invasive aspergillosis in a multivisceral transplant recipient

Transplant Proc. 2007 Jan-Feb;39(1):305-7. doi: 10.1016/j.transproceed.2006.10.015.

Abstract

Disseminated invasive aspergillosis is a serious and potentially lethal infectious complication of immunosuppressed individuals, including transplant recipients. We report here a successfully treated case of disseminated Aspergillus fumigatus infection involving the lungs, brain, and endocardium in a multivisceral transplant recipient. In addition to supportive measures, the patient was aggressively treated with a combination of three antifungal agents, and all immunosuppression was significantly lowered with close observation for rejection. After 3 months of therapy, the patient cleared the fungal infection, made a full recovery of his cerebral function, and was discharged to a rehabilitation facility.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnostic imaging*
  • Echocardiography, Transesophageal
  • Hepatitis B / surgery*
  • Humans
  • Intestine, Small / transplantation*
  • Liver Transplantation*
  • Magnetic Resonance Imaging
  • Male
  • Pancreas Transplantation*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / microbiology
  • Stomach / transplantation*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Amphotericin B